Shionogi & Co., Ltd. (4507.T)
JPY 2457.0
(1.84%)
JPY 2457.0
(1.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -346.47 Billion JPY | -15.56% |
| 2022 | -299.81 Billion JPY | -21.02% |
| 2021 | -247.74 Billion JPY | 7.62% |
| 2020 | -268.18 Billion JPY | -33.62% |
| 2019 | -200.7 Billion JPY | -4.19% |
| 2018 | -192.62 Billion JPY | -72.58% |
| 2017 | -111.61 Billion JPY | -43.48% |
| 2016 | -77.79 Billion JPY | -55.1% |
| 2015 | -50.15 Billion JPY | -142.86% |
| 2014 | -20.65 Billion JPY | -391.25% |
| 2013 | -4.2 Billion JPY | -108.86% |
| 2012 | 47.45 Billion JPY | -36.37% |
| 2011 | 74.57 Billion JPY | -6.1% |
| 2010 | 79.42 Billion JPY | -9.2% |
| 2009 | 87.46 Billion JPY | -4.56% |
| 2008 | 91.65 Billion JPY | 235.56% |
| 2007 | -67.6 Billion JPY | 6.72% |
| 2006 | -72.48 Billion JPY | -2.7% |
| 2005 | -70.57 Billion JPY | -2.34% |
| 2004 | -68.95 Billion JPY | -45.44% |
| 2003 | -47.41 Billion JPY | -10.87% |
| 2002 | -42.76 Billion JPY | -7.71% |
| 2001 | -39.7 Billion JPY | 41.04% |
| 2000 | -67.34 Billion JPY | -117.24% |
| 1999 | -30.99 Billion JPY | 34.52% |
| 1998 | -47.34 Billion JPY | 21.24% |
| 1997 | -60.1 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -300.11 Billion JPY | -11.18% |
| 2024 Q1 | -269.93 Billion JPY | 22.09% |
| 2023 Q3 | -274.94 Billion JPY | -13.18% |
| 2023 Q1 | -279.52 Billion JPY | 6.77% |
| 2023 Q2 | -242.93 Billion JPY | 13.09% |
| 2023 FY | -346.47 Billion JPY | -15.56% |
| 2023 Q4 | -346.47 Billion JPY | -26.02% |
| 2022 Q4 | -299.81 Billion JPY | -42.76% |
| 2022 FY | -299.81 Billion JPY | -21.02% |
| 2022 Q1 | -197.98 Billion JPY | 20.09% |
| 2022 Q2 | -191.22 Billion JPY | 3.41% |
| 2022 Q3 | -210.01 Billion JPY | -9.82% |
| 2021 Q1 | -198.57 Billion JPY | 25.96% |
| 2021 FY | -247.74 Billion JPY | 7.62% |
| 2021 Q4 | -247.74 Billion JPY | -27.57% |
| 2021 Q3 | -194.19 Billion JPY | 15.06% |
| 2021 Q2 | -228.62 Billion JPY | -15.14% |
| 2020 FY | -268.18 Billion JPY | -33.62% |
| 2020 Q1 | -162.01 Billion JPY | 19.28% |
| 2020 Q3 | -197.36 Billion JPY | 15.19% |
| 2020 Q4 | -268.18 Billion JPY | -35.88% |
| 2020 Q2 | -232.71 Billion JPY | -43.64% |
| 2019 Q2 | -225.33 Billion JPY | -16.1% |
| 2019 Q1 | -194.09 Billion JPY | -0.76% |
| 2019 Q4 | -200.7 Billion JPY | 13.35% |
| 2019 FY | -200.7 Billion JPY | -4.19% |
| 2019 Q3 | -231.61 Billion JPY | -2.79% |
| 2018 FY | -192.62 Billion JPY | -72.58% |
| 2018 Q2 | -181.22 Billion JPY | -52.07% |
| 2018 Q4 | -192.62 Billion JPY | -16.1% |
| 2018 Q3 | -165.91 Billion JPY | 8.45% |
| 2018 Q1 | -119.17 Billion JPY | -6.77% |
| 2017 Q1 | -79.21 Billion JPY | -1.82% |
| 2017 FY | -111.61 Billion JPY | -43.48% |
| 2017 Q4 | -111.61 Billion JPY | -15.11% |
| 2017 Q3 | -96.96 Billion JPY | -4.85% |
| 2017 Q2 | -92.47 Billion JPY | -16.75% |
| 2016 Q3 | -85.06 Billion JPY | -55.8% |
| 2016 Q4 | -77.79 Billion JPY | 8.55% |
| 2016 Q2 | -54.59 Billion JPY | 2.62% |
| 2016 Q1 | -56.06 Billion JPY | -11.79% |
| 2016 FY | -77.79 Billion JPY | -55.1% |
| 2015 Q3 | -48.77 Billion JPY | -10.56% |
| 2015 Q1 | -21.77 Billion JPY | -5.43% |
| 2015 Q2 | -44.11 Billion JPY | -102.6% |
| 2015 Q4 | -50.15 Billion JPY | -2.84% |
| 2015 FY | -50.15 Billion JPY | -142.86% |
| 2014 Q1 | -25 Billion JPY | -494.77% |
| 2014 Q3 | -29.62 Billion JPY | 10.87% |
| 2014 Q2 | -33.23 Billion JPY | -32.91% |
| 2014 Q4 | -20.65 Billion JPY | 30.28% |
| 2014 FY | -20.65 Billion JPY | -391.25% |
| 2013 Q2 | 38.31 Billion JPY | -18.96% |
| 2013 FY | -4.2 Billion JPY | -108.86% |
| 2013 Q4 | -4.2 Billion JPY | -114.37% |
| 2013 Q3 | 29.26 Billion JPY | -23.64% |
| 2013 Q1 | 47.28 Billion JPY | -0.36% |
| 2012 Q4 | 47.45 Billion JPY | -9.4% |
| 2012 FY | 47.45 Billion JPY | -36.37% |
| 2012 Q1 | 64.77 Billion JPY | -13.13% |
| 2012 Q2 | 60.35 Billion JPY | -6.83% |
| 2012 Q3 | 52.37 Billion JPY | -13.22% |
| 2011 Q3 | 82.03 Billion JPY | -4.46% |
| 2011 Q1 | 84.3 Billion JPY | 6.15% |
| 2011 Q4 | 74.57 Billion JPY | -9.1% |
| 2011 FY | 74.57 Billion JPY | -6.1% |
| 2011 Q2 | 85.86 Billion JPY | 1.85% |
| 2010 Q2 | 79.09 Billion JPY | 54.51% |
| 2010 Q3 | 88.32 Billion JPY | 11.66% |
| 2010 Q4 | 79.42 Billion JPY | -10.08% |
| 2010 Q1 | 51.19 Billion JPY | -41.48% |
| 2010 FY | 79.42 Billion JPY | -9.2% |
| 2009 Q3 | 96.15 Billion JPY | -2.46% |
| 2009 FY | 87.46 Billion JPY | -4.56% |
| 2009 Q4 | 87.46 Billion JPY | -9.03% |
| 2009 Q2 | 98.58 Billion JPY | 0.0% |
| 2008 Q4 | 91.65 Billion JPY | 0.0% |
| 2008 FY | 91.65 Billion JPY | 235.56% |
| 2007 FY | -67.6 Billion JPY | 6.72% |
| 2006 FY | -72.48 Billion JPY | -2.7% |
| 2005 FY | -70.57 Billion JPY | -2.34% |
| 2004 FY | -68.95 Billion JPY | -45.44% |
| 2003 FY | -47.41 Billion JPY | -10.87% |
| 2002 FY | -42.76 Billion JPY | -7.71% |
| 2001 FY | -39.7 Billion JPY | 41.04% |
| 2000 FY | -67.34 Billion JPY | -117.24% |
| 1999 FY | -30.99 Billion JPY | 34.52% |
| 1998 FY | -47.34 Billion JPY | 21.24% |
| 1997 FY | -60.1 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 28383.265% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 107.9% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 188.876% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -9621.059% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | -721.876% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | -463.604% |
| Eisai Co., Ltd. | -97.93 Billion JPY | -253.786% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -51844.528% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | -568.59% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -952.429% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 4657.616% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 4552.77% |
| Tsumura & Co. | 1.61 Billion JPY | 21553.251% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | -684.579% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | -906.098% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 300.613% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 1401.345% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 1295.476% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 5007.507% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 49314.489% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 5882.21% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -5216.398% |
| MedRx Co., Ltd | -1.72 Billion JPY | -20043.605% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -3874.892% |
| Solasia Pharma K.K. | -668 Million JPY | -51766.766% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -23454.374% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -4676.92% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 712.983% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -11602.012% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | -252.0% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -3013.05% |